NVCR NovoCure Limited gains 35% May 15, 2018

Markets a wearable electric field device for treating glioblastoma brain cancer.http://www.priceseries.com/trade/NVCR-NovoCure-Limited-stock-gains-35-percent-a-Trade-Record-by-priceSeries-2018041020180515.html

Posted by : priceSeries Tuesday, May 15, 2018

Subscribe by Email

Follow Updates Articles from This Blog via Email